Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke

Area of Science:

• Neurology
• Biochemistry
• Geriatrics

Background:

• Cerebral amyloid angiopathy (CAA) is a primary cause of intracerebral hemorrhage (ICH) in elderly individuals.
• Early and accurate diagnosis of CAA is crucial for managing neurological conditions.

Purpose of the Study:

• To identify plasma beta-amyloid (Aβ) species as potential biomarkers for diagnosing cerebral amyloid angiopathy (CAA).
• To differentiate between CAA subtypes and disease severity using plasma Aβ profiles.

Main Methods:

• Quantified plasma levels of Aβ(1-40), Aβ(N-40), Aβ(1-42), and Aβ(N-42) using xMAP® technology.
• Utilized CT scans and brain MRI for hemorrhage identification and classification.
• Assessed patients using the Boston criteria for probable or possible CAA.

Main Results:

• Elevated plasma levels of full-length Aβ(1-42) and truncated Aβ(N-42) were observed in probable CAA patients compared to controls.
• Full-length Aβ(1-40) was significantly higher in probable CAA cases versus possible CAA and controls.
• Increased plasma Aβ(N-42) correlated with the presence of multiple lobar macrohemorrhages, indicating a link to CAA severity.

Conclusions:

• Specific plasma Aβ fragments, particularly Aβ(1-42) and Aβ(N-42), show promise as diagnostic biomarkers for cerebral amyloid angiopathy (CAA).
• These Aβ species may aid in the early detection and characterization of CAA, improving patient management.